In several previous studies endogenous insulin and growth hormone have been reported as potent stimulants in intestinal turnover and potentially beneficial factors in the treatment of short bowel syndrome as part of their main anabolic and general regulatory action to overall body metabolic rate and weight balance [7,8]. Here, GH1 is linked to short bowel syndrome.